ATCO Pharma
인체 및 동물용 의약품 제조
ATCO Pharma는 이집트에서 인체 의약품, 수의학 제품 및 사료 첨가제를 제조합니다. 이 회사는 국내 및 지역 시장에 의료, 수의학 및 의약품 유통 채널을 공급합니다.
- Type
- manufacturer (our classification of the record, not a statement by the company)
- Role
- Manufacturer
- Location
- Cairo, Egypt
- Founded
- 1999
- Website
- https://www.atcopharma.com.eg
- Categories
- 의료 및 건강 관리 용품, 농업 및 원자재, 수의학 제품 및 동물 건강
- Markets
- 이집트, 사우디아라비아, 아랍에미리트
What is established and what is not
No facet of this company has been investigated yet. The facts below are collected records, not an assessment: nothing here confirms manufacturing, ownership or trading status beyond what each record literally says.
Verified facts
- corporate-mail-on-domain (green), checked 2026-08-04 Mail server of the company domain
- sanctions-clear (green), checked 2026-08-04 - screened by name only: no legal entity is established for this record, so this is not a clearance OpenSanctions
- debarment-clear (green), checked 2026-08-04 - screened by name only: no legal entity is established for this record, so this is not a clearance OpenSanctions
- named-by-manufacturer (green), effective since 2026-07-03 Celltrion distributor list
Import rules for these goods
- Medical devices sold in the EU must carry CE marking under the Medical Device Regulation (EU) 2017/745, with a conformity assessment matched to the device risk class. European Commission (MDR)
- For the US market, the maker must have an FDA device establishment registration and product listing; most instruments also need 510(k) premarket clearance. US FDA (devices)
- Veterinary medicines sold in the EU need a marketing authorisation under Regulation (EU) 2019/6, and importers need a manufacturing/import authorisation. European Medicines Agency (veterinary)